Henk De Feyter, PhD
Associate Professor of Radiology and Biomedical ImagingDownloadHi-Res Photo
Cards
Appointments
Contact Info
About
Titles
Associate Professor of Radiology and Biomedical Imaging
Appointments
Radiology & Biomedical Imaging
Associate Professor on TermPrimary
Other Departments & Organizations
- Bioimaging Sciences
- Deuterium Metabolic Imaging (DMI)
- Developmental Therapeutics
- Magnetic Resonance Research Center
- Magnetic Resonance Spectroscopy
- MR Center
- Radiology & Biomedical Imaging
- Yale Cancer Center
Education & Training
- Postdoctoral Associate
- Yale University (2010)
- PhD
- Eindhoven University of Technology, Department of Biomedical Engineering
- MSc
- Maastricht University, Department of Health, Medicine and Life Sciences
- MSc
- Ghent University, DEPARTMENT OF REHABILITATION SCIENCES
Research
Overview
Medical Research Interests
Biomarkers, Tumor; Magnetic Resonance Spectroscopy; Metabolic Networks and Pathways
ORCID
0000-0001-6111-0316
Research at a Glance
Yale Co-Authors
Frequent collaborators of Henk De Feyter's published research.
Publications Timeline
A big-picture view of Henk De Feyter's research output by year.
Research Interests
Research topics Henk De Feyter is interested in exploring.
Robin de Graaf, PhD
Robert Fulbright, MD
Antonio Omuro, MD
Joachim Baehring, MD
Nicholas Blondin, MD
Richard Carson, PhD
34Publications
1,461Citations
Magnetic Resonance Spectroscopy
Publications
2024
NIMG-30. DEUTERIUM METABOLIC IMAGING (DMI) SHOWS A STRONG RELATION BETWEEN TUMOR GRADE AND GLUCOSE METABOLISM IN PRIMARY BRAIN TUMORS
Thaw-Poon S, Blondin N, Liu Y, Corbin Z, Baehring J, Omuro A, Moliterno J, Omay S, Fulbright R, de Graaf R, De Feyter H. NIMG-30. DEUTERIUM METABOLIC IMAGING (DMI) SHOWS A STRONG RELATION BETWEEN TUMOR GRADE AND GLUCOSE METABOLISM IN PRIMARY BRAIN TUMORS. Neuro-Oncology 2024, 26: viii201-viii201. PMCID: PMC11553074, DOI: 10.1093/neuonc/noae165.0795.Peer-Reviewed Original ResearchConceptsGrade 2 lesionsTumor gradeDeuterium metabolic imagingMetabolic imagingNon-enhancing tumor regionsBrain tumorsTumor-to-brain contrastTumour-specific valuesActive tumor tissueImage contrastVOI-based analysisGrade 4Evaluate disease progressionTesla MRI scannerFDG-PETGrade 3Lesion gradeTumor tissuesDisease progressionDisease stageOral administrationTumorObservational studyNormal brainContrast enhancementNIMG-32. ORAL ADMINISTRATION OF DEUTERATED CHOLINE AS A NEW APPROACH TO PROVIDE HIGH TUMOR-TO-BRAIN IMAGE CONTRAST IN DEUTERIUM METABOLIC IMAGING (DMI)
Osoliniec V, Thomas M, de Graaf R, De Feyter H. NIMG-32. ORAL ADMINISTRATION OF DEUTERATED CHOLINE AS A NEW APPROACH TO PROVIDE HIGH TUMOR-TO-BRAIN IMAGE CONTRAST IN DEUTERIUM METABOLIC IMAGING (DMI). Neuro-Oncology 2024, 26: viii202-viii202. PMCID: PMC11552881, DOI: 10.1093/neuonc/noae165.0797.Peer-Reviewed Original ResearchConceptsTumor-to-brain contrastOral administrationMetabolic imagingDeuterium metabolic imagingIV infusionTCho concentrationOrthotopic models of glioblastomaNormal brainContralateral normal brainTumor-to-brainDays of oral administrationModels of glioblastomaAdministration of cholineTesla MRI scannerTCho signalMg/kg body weightOrthotopic modelFDG-PETOral administration of cholineTotal cholineDaily doseIntravenous infusionF344 ratsTail veinCholine metabolitesHigh-quality lipid suppression and B0 shimming for human brain 1H MRSI
Kumaragamage C, McIntyre S, Nixon T, De Feyter H, de Graaf R. High-quality lipid suppression and B0 shimming for human brain 1H MRSI. NeuroImage 2024, 300: 120845. PMID: 39276817, PMCID: PMC11540284, DOI: 10.1016/j.neuroimage.2024.120845.Peer-Reviewed Original ResearchAltmetricConceptsOuter volume suppressionInner volume selectionSlice coverageField shimmingLipid suppressionMRSI acquisitionMagnetic field shimmingMagnetic resonance spectroscopic imagingSpherical harmonic fieldsBrain non-invasivelyAxial coverageMulti-coilRadio frequencyVolume suppressionB0 shimmingBrain coverageGradient coilsHarmonic fieldVolume selectionGradient insertShimming performancePhantom experimentsField variationsSpectroscopic imagingProton magnetic resonance spectroscopic imagingB0 Eddy Current Compensation of an Unshielded Pulsed Z2 Gradient for Applications in Human Brain Proton MRSI
Kumaragamage C, Nixon T, McIntyre S, De Feyter H, de Graaf R. B0 Eddy Current Compensation of an Unshielded Pulsed Z2 Gradient for Applications in Human Brain Proton MRSI. Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2024 DOI: 10.58530/2024/3937.Peer-Reviewed Original ResearchTowards cardiac DMI at clinical field strengths
Xiang J, de Graaf R, De Feyter H, Thomas M, Baldassarre L, Kwan J, Coman D, Herman P, Peters D. Towards cardiac DMI at clinical field strengths. Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2024 DOI: 10.58530/2024/3052.Peer-Reviewed Original ResearchLipid removal in deuterium metabolic imaging (DMI) using spatial prior knowledge
de Graaf R, Liu Y, Corbin Z, De Feyter H. Lipid removal in deuterium metabolic imaging (DMI) using spatial prior knowledge. Magnetic Resonance 2024, 5: 21-31. DOI: 10.5194/mr-5-21-2024.Peer-Reviewed Original ResearchAltmetric
2023
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma
Khang M, Lee J, Lee T, Suh H, Lee S, Cavaliere A, Rushing A, Geraldo L, Belitzky E, Rossano S, de Feyter H, Shin K, Huttner A, Roussel M, Thomas J, Carson R, Marquez-Nostra B, Bindra R, Saltzman W. Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma. Science Translational Medicine 2023, 15: eadi1617. PMID: 37910601, PMCID: PMC11078331, DOI: 10.1126/scitranslmed.adi1617.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCerebrospinal fluidDelivery of drugsEffective therapyTherapeutic indexPARP inhibitorsBlood-brain barrierSite of tumorRapid systemic clearanceXenograft mouse modelSolvent evaporation processAdministration of substancesLeptomeningeal spreadIntrathecal deliveryLeptomeningeal metastasesBrain penetrationSystemic clearanceTumor regressionPolymer nanoparticlesMetastatic medulloblastomaMouse modelPediatric medulloblastomaDrug accumulationCSF turnoverEncapsulated drugsPET imagingImaging metabolism of deuterated glucose in patients with primary brain tumors
Corbin Z, Liu Y, Fulbright R, Thaw-Poon S, Baehring J, Blondin N, Kim P, Omuro A, Chiang V, Moliterno J, Omay S, Piepmeier J, Rothman D, de Graaf R, De Feyter H. Imaging metabolism of deuterated glucose in patients with primary brain tumors. Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2023 DOI: 10.58530/2023/0142.Peer-Reviewed Original ResearchIn vivo demonstration of arbitrary ROI shaping and B0 shimming with MC-ECLIPSE for applications in human brain proton MRSI
Kumaragamage C, McIntyre S, Nixon T, De Feyter H, de Graaf R. In vivo demonstration of arbitrary ROI shaping and B0 shimming with MC-ECLIPSE for applications in human brain proton MRSI. Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2023 DOI: 10.58530/2023/1238.Peer-Reviewed Original ResearchParallel Proton and Deuterium Metabolic Imaging
Liu Y, Kumaragamage C, Nixon T, McIntyre S, De Feyter H, de Graaf R. Parallel Proton and Deuterium Metabolic Imaging. Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2023 DOI: 10.58530/2023/3870.Peer-Reviewed Original Research
News
Get In Touch
Contacts
Locations
N139
Academic Office
The Anlyan Center
300 Cedar Street
New Haven, CT 06519